CAREFUSION CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 17 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-11-17: Reporting owner La Fortune Gordon; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-17: Reporting owner La Fortune Gordon; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-17: Reporting owner La Fortune Gordon; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-10: Reporting owner Abbey Donald; Form 3; Security Options (right to buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-11-17 | La Fortune Gordon Officer (EVP, Int'l. Commercial Ops) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −44 0 owned after | $17.77 exercise price | 2011-11-18 | |
| 2011-11-17 | La Fortune Gordon Officer (EVP, Int'l. Commercial Ops) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −314 0 owned after | $17.77 exercise price | 2011-11-18 | |
| 2011-11-17 | La Fortune Gordon Officer (EVP, Int'l. Commercial Ops) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −802 0 owned after | $17.77 exercise price | 2011-11-18 | |
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Options (right to buy) Derivative · Direct | Holding | $17.77 exercise price | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Options (right to buy) Derivative · Direct | Holding | $31.90 exercise price | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Options (right to buy) Derivative · Direct | Holding | $20.71 exercise price | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Options (right to buy) Derivative · Direct | Holding | $22.59 exercise price | 2011-11-10 | ||
| 2011-11-10 holding as of filing | Abbey Donald Officer (EVP, Quality Reg & Med Affairs) | 3 | Options (right to buy) Derivative · Direct | Holding | $25.56 exercise price | 2011-11-10 | ||
| 2011-08-15 | Stafslien Joan Officer (EVP, General Counsel) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,207 69,207 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-08-15 | Maschal Jean Officer (SVP, Chief Accounting Officer) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,061 27,061 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-08-15 | MARCHETTI ROGER Officer (EVP, Human Resources) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,626 44,626 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-08-15 | Leonard Thomas J Officer (President, Medical Systems) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +76,586 76,586 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-08-15 | Jain Vivek Officer (Pres., Procedural Solutions) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,353 80,353 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-08-15 | La Fortune Gordon Officer (EVP, International Operations) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,706 40,706 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-08-15 | Hinrichs James F. Officer (Chief Financial Officer) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +160,187 160,187 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-08-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +503,306 503,306 owned after | $25.56 exercise price | 2011-08-16 | |
| 2011-02-15 | Gallahue Kieran Director, Officer (Chairman and CEO) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +633,110 633,110 owned after | $27.84 exercise price | 2011-02-17 |